Our unique flow technology systems are used to compress reaction stages and reduce months out of delivery programs, while significantly improving process safety, economics and scalability.

Collaboration, project management and strong communication are vital for successful new product introduction (NPI) and technology transfer—the processes required to progress from drug discovery all the way through to commercialization. Our CDMOs provide the capability, discipline and experience in NPI and technology transfer, both within their organization and externally. Our NPI and technology transfer teams are formed with experts in a wide range of areas, including project management, development, quality assurance and regulatory affairs.

Our teams adopt flexibility and agility for more efficient drug development. Flexibility is key to the fast delivery of drug substances and drug products. Our CDMO’s provide a fully integrated package of services or a bespoke offering to meet a client’s particular requirements. We have the ability to take on both small and largescale project.

We increase the Efficiency through the employment of synthetic biology for drug substance development. The interdisciplinary branch of biology and engineering are used to significantly shorten the number of process stages, with the prospect of eliminating some stages entirely. By harnessing the metabolic pathways found in nature, drug substance manufacture can be simplified with the potential to produce drug compounds more efficiently from different starting points

We have excellent coherent project metrics and IT systems for accurate measurement of delivery to provide an advantage when applying a more flexible approach to drug development. Guidance on formulation and solid-state parameters, from integrated solid-state teams, provide drug substance chemists with clear and unambiguous data for optimizing drug substance form, also lead to rapid drug substance and drug product delivery.

It’s our constant endeavour to adopt digital manufacturing platforms for short bespoke runs of drug products at an affordable cost. One project involves the development of novel production equipment that uses robotic capsule filling systems for greater speed and dosage accuracy. We believe the industry is ready to take on these challenges and modern CDMOs have the technologies in place to provide a secure source of delivery for technically complex projects.